MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

1 month ago 5
Read Entire Article
  1. Homepage
  2. Finance
  3. MaaT Pharma Announces Promising Final Data Readout for Phase 1b Evaluating MaaT033 in Amyotrophic Lateral Sclerosis (ALS)

Related

Israeli fire kills 12 people in Gaza, medics say

Israeli fire kills 12 people in Gaza, medics say

23 minutes ago 0
Investigational combination of first-in-class bispecifics TALVEY ® and TECVAYLI ® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Investigational combination of first-in-class bispecifics TA...

23 minutes ago 0
Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025

Positive Late-Breaking Data for Incyte's First-in-Class mutC...

23 minutes ago 0

Trending

1. spectrum outage
2. xm
3. seatac airport flights
4. league of legends
5. steven universe
6. wordle june 15
7. osu
8. dakota johnson chris martin
9. restaurant
10. apartments

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

4 months ago 268
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

3 months ago 149
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

5 months ago 147
TOUS les JOURS Opens in Henderson!

TOUS les JOURS Opens in Henderson!

4 months ago 116
Sole mates: Find the perfect shoes for your fitness journey

Sole mates: Find the perfect shoes for your fitness journey

4 months ago 111
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved